First Wisconsin patient - new neuroendocrine tumor drug

Service Area: Cancer

Noelle  LoConte 

Priscilla is the first Wisconsin patient treated with new neuroendorine tumor drug

Cancer

University of Wisconsin Hospitals and Clinics Authority

We use cookies on this site to enhance your experience and improve our marketing efforts. By continuing to browse without changing your browser settings to block or delete cookies, you agree to the storing of cookies and related technologies on your device.

Language Access:  Notice of Nondiscrimination

UW Health Logo

Donations to UW Health are managed by the University of Wisconsin Foundation, a publicly supported charitable organization under 501(c)(3) of the Internal Revenue Code.

⚠ Provider CTA Opt Out

Referencing this link within an Intake Form URL field will override and ignore Links lower in the hierarchy (Clinic Specialty > Specialty > Location)